News

Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors
Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed ...
Electrospun microfibers enhance nutrient supply in bioinks and 3D-bioprinted tissue
D bioprinting holds great potential in the field of regenerative medicine to produce miniaturized tissues and organ ...
Med Device Online3d
EC Rep To EU Rep: The Symbol Shift You Can't Ignore
The recent update to ISO 15223-1, formalized through Amendment 1:2025, ushers in a critical shift for medical device labeling ...
Orchestra BioMed granted breakthrough device designation, says H.C. Wainwright
H.C. Wainwright reiterates a Buy rating and $12 price target on shares of Orchestra BioMed (OBIO) after the company announced that the Food and ...
pharmaphorum3d
Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal
Zurich-based start-up Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...
Opinion
Cocorioko5dOpinion
From manifesto to mayhem: Why President Bio’s New Direction failed to transform Sierra Leone
Agricultural revitalisation—especially rice production—was a central promise of the New Direction. Yet by 2022, Sierra Leone was still importing over $200 million in rice annually. According to the ...
Jawline goals: Experts reveal 4 ways to sculpt a snatched look without surgery
Whether to correct a weak jawline, restore lost volume, achieve a more sculpted appearance, dermal fillers are a safe, ...